Apposite reaps 45% IRR on SureCalm exit
Specialist healthcare investor Apposite Capital has sold homecare services provider SureCalm Healthcare to medical technologies developer Amcare Ltd, reaping a 45% IRR.
Amcare Ltd is a wholly-owned subsidiary of ConvaTec UK Holdings Ltd, developer and marketer of medical technologies for community and hospital care.
Previous funding 
In January 2010, Apposite Capital created SureCalm Healthcare as part of the management buy-in of three private dispensing appliance contractors focusing on stoma, urology and continence care. The all-equity deal value was estimated to be in excess of £25m.
Company 
SureCalm was created from the merger of Alphamed, BCA Direct and Homestyle Positive. The three component companies, founded in 1991, 1995 and 1993 respectively, had a combined turnover of £13m in 2009. SureCalm is headquartered in Surrey and employs around 65 members of staff.
People
Sam Gray is a partner at Apposite and led the transaction. Kevin Hodges is cofounder and CEO of SureCalm.
Advisers 
Vendor - Berwin Leighton Paisner LLP (Legal); Hazelwood (Corporate finance).
Acquirer - Wragges & Co (Legal); Ernst & Young (Financial due diligence).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds








